The clinical spectrum of 69 episodes of metapneumovirus pediatric infection (55 episodes caused by genotype A and 14 episodes caused by genotype B) was analyzed. Diagnosis of pneumonia was more common and the illness severity index (determined on the basis of need for hospitalization, oxygen saturation !90%, and intensive care unit stay) was higher for patients with metapneumovirus genotype A infection.
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Human metapneumovirus (hMPV) is a recently described virus that causes acute respiratory illness (ARI) in individuals of all ages [1] but is especially prevalent in children [2] . The genetic diversity shown by strains has allowed 2 major groups or genotypes of hMPV (genotype A and genotype B) to be defined [3, 4] . Both genotypes circulate simultaneously throughout the world. To date, the question of whether genotypes A and B differ in virulence has not been established. In the present study, we analyze the clinical characteristics and severity of ARI episodes caused by hMPV genotype A and genotype B in children in Gipuzkoa (Basque Country), Spain.
Materials and methods. For 4 consecutive seasons (July 2001-June 2005), we routinely investigated the presence of hMPV in the nasopharyngeal aspirates of children aged !3 years who attended the pediatric emergency unit of Hospital Donostia (San Sebastián, Spain) with an episode of ARI. In all samples, hMPV was determined by PCR, whereas detection of adenovirus, respiratory syncytial virus, and influenza and parainfluenza virus was performed by cell culture and PCR [5] .
PCR for hMPV detection was performed using primers derived from the F gene under previously described conditions [6] . During the 2 last seasons, a second PCR was performed using primers derived from the polymerase gene [7] . The F gene fragment amplified (450 bp) from the hMPV-positive samples was sequenced to confirm the result. Sequence alignment of the F gene with each other and with published sequences of hMPV, using the ClustalX multiple sequence alignment program, determined the respective hMPV genotype. Demographic and clinical data corresponding to episodes of hMPV infection were obtained retrospectively through review of patients' medical records. A severity index was created through an illness score that ranged from 0 to 3. A single point was assigned to each of the following 3 parameters: need for hospitalization, oxygen saturation !90% at hospital admission, and intensive care unit stay (1 point if present, 0 points if absent).
Statistical analysis was performed using the G-Stat 1.1 program. Dichotomic variables were analyzed by the x 2 test, with application of the 2-tailed Fischer's exact test when necessary. Quantitative variables were analyzed through comparisons between mean values with the Mann-Whitney U test. A P value of р.05 was considered to be statistically significant. Results. Between July 2001 and June 2005, a total of 2405 nasopharyngeal aspirates from children with ARI were analyzed. hMPV was detected in 96 episodes (4%), 27 of which were excluded from the study, either because they were mixed with other respiratory viruses (12 coinfections with respiratory syncytial virus, 1 coinfection with virus influenza A, 1 coinfection with parainfluenza type 3, 1 coinfection with parainfluenza type 4, and 1 coinfection with adenovirus) or because no hMPV genogrouping could be performed (11 episodes). The 69 included episodes occurred in 69 different children (53 infants aged !12 months, 12 children aged 12-23 months, and 4 children aged 24-35 months). Underlying conditions were present in 10 patients (14%) and included prematurity in 5 patients (1 of whom had West syndrome), congenital heart disease in 4 patients (2 of whom had Down syndrome), and bronchopulmonary dysplasia in 1 patient.
Genetic analyses of the viruses classified 55 strains into hMPV genotype A (13 strains classified subtype A1 and 42 strains classified subtype A2) and 14 into genotype B (13 strains classified subtype B1 and 1 strain classified subtype B2). Nucleotide identity between genotypes A and B was 84%-88%, and nucleotide identity was 94%-100% and 97%-100% within genotypes A and B, respectively. Most cases occurred between December and May, and simultaneous circulation of strains of both genotypes was found throughout the 4 seasons studied.
Of 55 children with hMPV genotype A infection, bronchiolitis was diagnosed in 22, pneumonia in 15 (confirmed by clinical and radiographic criteria), wheezy bronchitis in 7, upper ARI in 6, acute bronchitis in 3, and febrile syndrome in 2. The diagnosis among the 14 hMPV genotype B-infected children was bronchiolitis in 6 episodes, upper ARI in 5 episodes, and wheezy bronchitis, apnea and febrile syndrome in 1 episode, respectively. Analysis of demographic data and underlying conditions revealed no significant differences between the 2 genotypes (table 1). Pneumonia diagnosis was only observed in patients with hMPV genotype A (15 vs. 0 episodes; P p ). With respect to the severity index, the mean illness score .03 was higher for episodes of ARI caused by hMPV genotype A (median score, 1; range, 0-3) than for those caused by hMPV genotype B (median score, 0; range, 0-1;
). Differences P p .02 in the severity index between the 2 genotypes were the same when the children with underlying conditions were removed from the analysis (median score, 1 [range, 0-3] vs. 0 [range, 0-1];
). P p .04 Discussion. During the first few years of life, hMPV infection represents a leading cause of ARI, with a highly varied spectrum of disease, ranging from mild infections to severe disease requiring hospitalization [2, 8] . In the present study, comparison of objective criteria associated with the infection severity for each of the 2 genotypes of hMPV suggests that, in small children, ARI due to hMPV genotype A is more severe than ARI due to hMPV genotype B. Significant differences were found in the comparison of individual parameters that reflect greater severity (e.g. pneumonia), as well as in the severity index, which combined clinical data (i.e., data on hypoxemia) and data on medical interventions (i.e., data on hospital admission and intensive care unit stay). These results cannot be attributed to the presence of underlying conditions, because the results did not vary when children with underlying conditions were excluded from analysis.
The association of hMPV infection with asthma has been reported by other authors, who have suggested that hMPV is a causative agent of acute wheezing in young children [9, 10] . We found a history of asthma in 17 hMPV-infected children (24.6%), and the episode was diagnosed as wheezy bronchitis in 8 (11.6%). In this study, significant differences in history of asthma or wheezy bronchitis were not found between children infected with genotype A hMPV and children infected with genotype B hMPV.
The different severity observed could be attributable to a higher virulence of hMPV genotype A. The mechanism through which some groups or genotypes of virus cause more-severe illness is unknown, but differences in pathogenicity could result from functional differences in the viral genome or proteins [11] . In hMPV, the genetic differences between genotypes A and B are also reflected in differences in antigenicity, with 2 hMPV serotypes being defined [3] . hMPV infection by one genotype might protect from a future infection by the other genotype. In our study population, more cases of hMPV genotype A infection were found, as reported in previous studies from other areas [4, 12] . This could be explained as the result of a lesser infectivity of hMPV genotype B or, more probably, as the result of a milder disease caused by hMPV genotype B in children that does not require hospitalizations as frequently as hMPV genotype A infection.
To our knowledge, this is the first study that suggests that hMPV genotype A might be more pathogenic than hMPV genotype B. Nevertheless, these preliminary findings must be confirmed with more studies performed in different regions of the world.
